Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Cardiology

The Biology and Diagnosis of Your Heart Condition

At a Glance

Rheumatic heart disease develops when an immune response after a Group A Streptococcus infection mistakenly attacks the heart valves. An echocardiogram looks for valve thickening, restricted movement, narrowing, leakage, and effects on heart function.

Understanding the biology of rheumatic heart disease (RHD) and the technical language in your medical report can help you feel more in control of your care. RHD is the result of a complex chain reaction in your immune system that begins with a bacterial infection but ends with your own body’s defenses attacking your heart [1].

The Biology of “Friendly Fire”

The root cause of RHD is a bacterium called Group A Streptococcus (GAS) [1]. While the bacteria themselves do not infect the heart, they carry proteins (like the M-protein) that look remarkably similar to proteins found in your heart valves and muscle [2][3].

When your immune system fights the strep throat, it creates cross-reactive antibodies and autoreactive T cells—essentially “soldiers” that get confused [4][3]. Because of this molecular mimicry, these soldiers begin to attack the heart valves as if they were the bacteria [1][5]. This “friendly fire” leads to inflammation, which eventually turns into permanent scarring and distortion of the valves [6][7].

Decoding Your Echocardiogram Report

An echocardiogram (“echo”) is an ultrasound that allows doctors to see the structure and movement of your heart. In 2023, the World Heart Federation (WHF) updated the official guidelines for diagnosing RHD based on these scans [8]. Your cardiologist will interpret the scan to see if findings fit the criteria:

  • Definite RHD: This is diagnosed when there is a clear pattern of valve shape (morphology) and blood flow (Doppler) abnormalities that meet age-specific and valve-specific thresholds [9][10].
  • Borderline RHD: This describes “early” or “mild” findings that are suspicious but do not yet meet the full criteria for a definite diagnosis [11][12]. These cases often require careful monitoring to see if they progress or resolve [13].

Common Technical Terms

  • Leaflet Thickening: The valve flaps (leaflets) become thicker than normal due to inflammation and scarring [9].
  • Commissural Fusion: The edges where the valve leaflets meet begin to stick together, making it hard for the valve to open fully [9].
  • Restricted Leaflet Mobility: The valve flaps cannot move freely, often because they are stiff or scarred [6].
  • Neovascularization: The growth of new, abnormal blood vessels within the heart valve tissue; this is a microscopic pathology term usually seen only in biopsies or surgery, not on a routine echo [14].
  • Calcification: In later stages, hard calcium deposits can form on the valves, making them very stiff [15].
  • Aschoff Bodies: Microscopic areas of inflammation found during the “acute” phase of rheumatic fever; these are rarely seen on an echo but may be mentioned in surgical or biopsy reports [14].

Report Completeness Checklist

A high-quality echocardiogram report for RHD should provide a complete picture of your heart’s health. Ensure your report includes:

  1. Valve Anatomy: Detailed description of the mitral, aortic, and tricuspid valves [9].
  2. Stenosis vs. Regurgitation: Does the valve leak (regurgitation) or is it too narrow (stenosis)? The report should specify the severity (mild, moderate, or severe) [16][17].
  3. Chamber Sizes: Measurements of the left atrium and ventricles to see if the heart is stretching or enlarging due to valve stress [9][18].
  4. Pressures: An estimate of the pulmonary artery pressure (blood pressure in the lungs), which can rise if the heart valves are not working correctly [9].
  5. Heart Function: Often reported as the ejection fraction (EF), which measures how well the heart pumps blood [18].

Is It Definitely RHD? (Look-Alikes)

Not all valve problems are caused by RHD. Doctors must rule out “look-alike” conditions, including:

  • Mitral Valve Prolapse (MVP): A common, often genetic condition where the valve leaflets are “floppy” or redundant, but not scarred by inflammation [19].
  • Congenital Defects: Some people are born with valve issues, such as a bicuspid aortic valve (having two flaps instead of three) [20].
  • Infective Endocarditis: A direct bacterial infection of the heart valve that can cause sudden damage and “growths” called vegetations [21].
  • Physiologic Regurgitation: Many healthy people have tiny, normal leaks in their heart valves that can sometimes be mistaken for early disease on a sensitive scan [12].

If your result is borderline or unclear, your doctor will typically recommend expert review or a repeat standard scan; in specific cases such as suspected clot or procedural planning, they may order a more detailed transesophageal echocardiogram (TEE) [20][11].

Common questions in this guide

What causes rheumatic heart disease?
Rheumatic heart disease can develop after a Group A Streptococcus infection, such as strep throat. The immune system may mistakenly attack heart valve tissue because some bacterial proteins resemble proteins in the heart, causing inflammation and later scarring.
What is the difference between definite and borderline rheumatic heart disease?
Definite rheumatic heart disease means the valve shape and blood-flow findings on an echocardiogram meet established diagnostic criteria. Borderline rheumatic heart disease means the findings are suspicious or early but do not meet all criteria, so expert review or a repeat scan may be recommended.
What should be included in a rheumatic heart disease echocardiogram report?
A useful report describes the mitral, aortic, and tricuspid valves, including whether they are narrowed or leaking and how severe the problem is. It may also include heart chamber size, pressure in the lung arteries, and ejection fraction, which reflects how well the heart pumps.
Can another condition look like rheumatic heart disease on an echocardiogram?
Yes. Mitral valve prolapse, a congenital bicuspid aortic valve, infective endocarditis, and small normal valve leaks can resemble some rheumatic heart disease findings. Your cardiologist considers the valve appearance, blood-flow pattern, medical history, and sometimes follow-up imaging.
What do valve thickening, restricted movement, or commissural fusion mean?
These terms describe structural changes in a heart valve. Thickening and reduced movement can reflect stiffness or scarring, while commissural fusion means parts of the valve edges have joined and may prevent the valve from opening normally.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific features of my valves were seen on the echo, such as thickening, restricted motion, or commissural fusion?
  2. 2.Does my report meet the 2023 WHF criteria for 'Definite' or 'Borderline' RHD?
  3. 3.What was the length and velocity of the 'regurgitant jet' on my scan, and does it meet the threshold for 'pathological' regurgitation?
  4. 4.Could these valve changes be caused by something else, like a congenital defect or myxomatous mitral valve prolapse?
  5. 5.Do we need a follow-up transthoracic echocardiogram to monitor these findings?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

    Cunningham MW

    Microbiology spectrum 2019; (7(4)) doi:10.1128/microbiolspec.GPP3-0045-2018.

    PMID: 31373269
  2. 2

    Genome-Wide Analysis of Genetic Risk Factors for Rheumatic Heart Disease in Aboriginal Australians Provides Support for Pathogenic Molecular Mimicry.

    Gray LA, D'Antoine HA, Tong SYC, et al.

    The Journal of infectious diseases 2017; (216(11)):1460-1470 doi:10.1093/infdis/jix497.

    PMID: 29029143
  3. 3

    Rapid screening for acute rheumatic fever using machine learning analysis of host tissue reactive antibodies.

    Vo B, Rafeek RAM, Surve NZ, et al.

    Scientific reports 2025; (15(1)):41316 doi:10.1038/s41598-025-25171-5.

    PMID: 41271880
  4. 4

    Dysregulated IL-1β-GM-CSF Axis in Acute Rheumatic Fever That Is Limited by Hydroxychloroquine.

    Kim ML, Martin WJ, Minigo G, et al.

    Circulation 2018; (138(23)):2648-2661 doi:10.1161/CIRCULATIONAHA.118.033891.

    PMID: 30571257
  5. 5

    Inflammatory Responses Potentiate GAS M Protein Induced Cardiac Damage in an Experimental Model of Rheumatic Heart Disease.

    Rafeek RAM, Reynolds SL, Pandey M, et al.

    Immunity, inflammation and disease 2025; (13(7)):e70221 doi:10.1002/iid3.70221.

    PMID: 40642941
  6. 6

    Inhibition of Endothelial-Mesenchymal Transition Mediated by Activin Receptor Type IIA Attenuates Valvular Injury Induced by Group A Streptococcus in Lewis Rats.

    Lu Z, Li Y, Lu C, et al.

    Frontiers in bioscience (Landmark edition) 2025; (30(1)):26370 doi:10.31083/FBL26370.

    PMID: 39862082
  7. 7

    Valve biology and rheumatic heart disease pathogenesis.

    Yeow S, Frost H, Porrello ER, et al.

    Nature cardiovascular research 2026; (5(3)):204-217 doi:10.1038/s44161-026-00792-9.

    PMID: 41807679
  8. 8

    2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease.

    Rwebembera J, Marangou J, Mwita JC, et al.

    Nature reviews. Cardiology 2024; (21(4)):250-263 doi:10.1038/s41569-023-00940-9.

    PMID: 37914787
  9. 9

    Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography.

    Pandian NG, Kim JK, Arias-Godinez JA, et al.

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2023; (36(1)):3-28 doi:10.1016/j.echo.2022.10.009.

    PMID: 36428195
  10. 10

    Using a Low-Risk Population to Estimate the Specificity of the World Heart Federation Criteria for the Diagnosis of Rheumatic Heart Disease.

    Clark BC, Krishnan A, McCarter R, et al.

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2016; (29(3)):253-8.

    PMID: 26725186
  11. 11

    The Echocardiographic Diagnosis of Rheumatic Heart Disease: A Review of the Performance of the World Heart Federation Criteria 2012-2023.

    Marangou J, Rwebembera J, Mwita J, et al.

    Global heart 2024; (19(1)):47 doi:10.5334/gh.1327.

    PMID: 38765776
  12. 12

    Valvular Regurgitation Using Portable Echocardiography in a Healthy Student Population: Implications for Rheumatic Heart Disease Screening.

    Webb RH, Gentles TL, Stirling JW, et al.

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2015; (28(8)):981-8.

    PMID: 25959548
  13. 13

    Screening-detected rheumatic heart disease can progress to severe disease.

    Engelman D, Wheaton GR, Mataika RL, et al.

    Heart Asia 2016; (8(2)):67-73 doi:10.1136/heartasia-2016-010847.

    PMID: 27933106
  14. 14

    Chronic rheumatic heart disease with recrudescence of acute rheumatic fever on histology: a case report.

    Mutithu DW, Roberts R, Manganyi R, Ntusi NAB

    European heart journal. Case reports 2022; (6(7)):ytac278 doi:10.1093/ehjcr/ytac278.

    PMID: 35865226
  15. 15

    Association Between the Expression of T Helper Type 17 Cell-Related Cytokines and Valve Damage in Rheumatic Heart Disease.

    Zhang C, Xiao Z, Yang D

    Molecular biotechnology 2025; (67(11)):4257-4270 doi:10.1007/s12033-024-01321-4.

    PMID: 39576560
  16. 16

    Cardiac MR Imaging in the Evaluation of Rheumatic Valvular Heart Diseases.

    Mutnuru PC, Singh SN, D'Souza J, Perubhotla LM

    Journal of clinical and diagnostic research : JCDR 2016; (10(3)):TC06-9 doi:10.7860/JCDR/2016/18059.7405.

    PMID: 27134962
  17. 17

    Inter-rater and intra-rater reliability and agreement of echocardiographic diagnosis of rheumatic heart disease using the World Heart Federation evidence-based criteria.

    Remenyi B, Carapetis J, Stirling JW, et al.

    Heart Asia 2019; (11(2)):e011233 doi:10.1136/heartasia-2019-011233.

    PMID: 31297166
  18. 18

    Left ventricular remodelling in rheumatic heart disease - trends over time and implications for follow-up in childhood.

    MacDonald B, Tarca A, Causer L, et al.

    BMC cardiovascular disorders 2023; (23(1)):462 doi:10.1186/s12872-023-03497-0.

    PMID: 37715115
  19. 19

    Imaging for the assessment of the arrhythmogenic potential of mitral valve prolapse.

    Esposito A, Gatti M, Trivieri MG, et al.

    European radiology 2024; (34(7)):4243-4260 doi:10.1007/s00330-023-10413-9.

    PMID: 38078997
  20. 20

    Predominant Rheumatic Tricuspid Stenosis.

    Alizadeh L, Vainrib AF, Ro R, et al.

    JACC. Case reports 2025; (30(33)):104808 doi:10.1016/j.jaccas.2025.104808.

    PMID: 41136055
  21. 21

    Diagnosis of infective endocarditis using echocardiography.

    Yuan XC, Liu M, Hu J, et al.

    Medicine 2019; (98(38)):e17141 doi:10.1097/MD.0000000000017141.

    PMID: 31567953

This page explains rheumatic heart disease biology and echocardiogram terminology for informational purposes only and does not constitute medical advice. Ask your cardiologist to interpret your results and recommend appropriate follow-up.

Get notified when new evidence is published on rheumatic heart disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.